Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 1
1947 2
1949 4
1951 1
1952 2
1953 7
1954 6
1955 3
1956 3
1958 1
1959 4
1960 7
1961 7
1962 9
1963 12
1964 11
1965 7
1966 7
1967 3
1968 3
1969 5
1970 6
1971 2
1972 3
1973 7
1974 5
1975 10
1976 10
1977 11
1978 6
1979 8
1980 11
1981 4
1982 23
1983 13
1984 18
1985 19
1986 17
1987 23
1988 21
1989 25
1990 20
1991 18
1992 23
1993 19
1994 19
1995 16
1996 21
1997 22
1998 11
1999 19
2000 21
2001 28
2002 23
2003 23
2004 33
2005 41
2006 27
2007 43
2008 56
2009 37
2010 49
2011 49
2012 44
2013 55
2014 50
2015 48
2016 53
2017 42
2018 65
2019 42
2020 1
Text availability
Article attribute
Article type
Publication date

Search Results

1,277 results
Results by year
Filters applied: . Clear all
Page 1
The Conversion Ratio From Intravenous Hydromorphone to Oral Opioids in Cancer Patients.
Reddy A, Vidal M, Stephen S, Baumgartner K, Dost S, Nguyen A, Heung Y, Kwan S, Wong A, Pangemanan I, Azhar A, Tayjasanant S, Rodriguez E, Waletich J, Lim KH, Wu J, Liu D, Williams J, Yennurajalingam S, Bruera E. Reddy A, et al. J Pain Symptom Manage. 2017 Sep;54(3):280-288. doi: 10.1016/j.jpainsymman.2017.07.001. Epub 2017 Jul 13. J Pain Symptom Manage. 2017. PMID: 28711751
Hydromorphone for cancer pain.
Bao YJ, Hou W, Kong XY, Yang L, Xia J, Hua BJ, Knaggs R. Bao YJ, et al. Cochrane Database Syst Rev. 2016 Oct 11;10(10):CD011108. doi: 10.1002/14651858.CD011108.pub2. Cochrane Database Syst Rev. 2016. PMID: 27727452 Free PMC article. Review.
Opioids for cancer pain - an overview of Cochrane reviews.
Wiffen PJ, Wee B, Derry S, Bell RF, Moore RA. Wiffen PJ, et al. Cochrane Database Syst Rev. 2017 Jul 6;7(7):CD012592. doi: 10.1002/14651858.CD012592.pub2. Cochrane Database Syst Rev. 2017. PMID: 28683172 Free PMC article. Review.
Assessment of hydromorphone and dexmedetomidine for emesis induction in cats.
Nystrom MR, Odunayo A, Okafor CC. Nystrom MR, et al. J Vet Emerg Crit Care (San Antonio). 2019 Jul;29(4):360-365. doi: 10.1111/vec.12866. Epub 2019 Jun 25. J Vet Emerg Crit Care (San Antonio). 2019. PMID: 31240797 Clinical Trial.
Hydromorphone protects CA1 neurons by activating mTOR pathway.
Xie W, Xie W, Kang Z, Jiang C, Liu N. Xie W, et al. Neurosci Lett. 2018 Nov 20;687:49-54. doi: 10.1016/j.neulet.2018.09.029. Epub 2018 Sep 17. Neurosci Lett. 2018. PMID: 30236878
The pharmacokinetics and pharmacodynamics of intravenous hydromorphone in horses.
Reed R, Barletta M, Mitchell K, Hanafi A, Bullington A, Knych H, Quandt J, Ryan C, Giguère S. Reed R, et al. Vet Anaesth Analg. 2019 May;46(3):395-404. doi: 10.1016/j.vaa.2018.11.001. Epub 2018 Nov 22. Vet Anaesth Analg. 2019. PMID: 30930095 Clinical Trial.
Randomized Trial of Intravenous Lidocaine Versus Hydromorphone for Acute Abdominal Pain in the Emergency Department.
Chinn E, Friedman BW, Naeem F, Irizarry E, Afrifa F, Zias E, Jones MP, Pearlman S, Chertoff A, Wollowitz A, Gallagher EJ. Chinn E, et al. Ann Emerg Med. 2019 Aug;74(2):233-240. doi: 10.1016/j.annemergmed.2019.01.021. Epub 2019 Feb 26. Ann Emerg Med. 2019. PMID: 30819520 Clinical Trial.
1,277 results
Jump to page
Feedback